Is there a generic for Viibryd available?

How long until a generic for Viibryd is available?

The patent for Viibryd, also known as vilazodone, is held by Allergan [1] and is set to expire in 2028 in the United States [2]. This means that generic versions of the medication will likely become available once the patent expires.

Can I buy a generic version of Viibryd now?

Unfortunately, no generic version of Viibryd is currently available due to the patent being in effect [3]. However, some pharmacies may offer generic vilazodone, but these versions are likely not FDA-approved and of unknown quality.

What is the price of generic vilazodone?

Prices for generic vilazodone are not publicly available as no generic version has been approved yet. However, once generic versions become available, they are typically cheaper than brand-name medications, with price competition driving down costs.

Are biosimilars coming for Viibryd?

As patent exclusivity expires, biosimilar manufacturers may enter the market with their own versions of vilazodone. Biosimilars are complex medicines that mimic the molecular structure of a biologic drug, offering similar efficacy at a lower price.

Sources:

[1] Allergan, Patent Holder of Viibryd (vilazodone)
[2] Drugs.com, Patent Expiration Date for Viibryd (vilazodone)
[3] Genericpharmaindex.com, Generic version of Viibryd (vilazodone)

Note: The expiration dates for patents can change, and the availability of generic forms of a medication is subject to FDA approval. For up-to-date information, consult a healthcare professional or the FDA website.